Advancing Heart, Lung, Blood, and Sleep Research & Innovation | NHLBI, NIH
Skip to main content
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Leading the prevention and treatment of heart, lung, blood, and sleep disorders
Sarcoidosis is a condition that develops when groups of cells in the immune system form red and swollen lumps, called granulomas, in various organs in the body.
Discover research programs and initiatives that seek to inform prevention, diagnosis, and treatment for today’s major health challenges and conditions.
Heart Failure
NHLBI-supported research has contributed to heart failure treatments using breakthrough therapies.
BioData Catalyst is a cloud-based ecosystem where researchers can analyze data related to NHLBI focus areas, like Long COVID, sickle cell disease, asthma, and heart disease.
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives.